Schedule 13G ownership disclosure
Skye Bioscience, Inc.
Security class unavailable · CUSIP: 83086J101
Event date: 2023-08-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 629,022,108
- Percent of class
- 19.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-096005
- Form type
- SC 13G
- Filer
- Skye Bioscience, Inc.
- CIK
- CIK 1516551
- Filed
- Aug 28, 2023
- Reporting period
- Aug 18, 2023
- Description
- Schedule 13G beneficial ownership